Mood and Psychotic Disorders Biodesign workshop - Nottingham
However, 75% of people with mental illness currently receive no treatment and even when people are referred to NHS psychological services, 60% still receive no treatment.
Mood disorders are comprised of a range of mental illnesses which include depression, anxiety disorders and bipolar disorder. They can affect people of all ages; 10% of British 5-15 year olds have a diagnosable mental health condition but only 25% of these receive support. More than 75% of adults who access mental health services had a diagnosable disorder prior to the age of 18. There are also a range of psychotic disorders such as schizophrenia and mood and psychotic disorders are often combined. Self-harm, suicidal feelings and other symptoms of mental illness are closely related to both mood and psychotic disorders.
Mood disorders are often treated with antidepressant and mood stabilising medicines; however, these can cause a wide range of unpleasant side effects. There are a range of non-pharmaceutical treatments currently being investigated and some are already available for patients. Neuromodulation techniques such as transcranial magnetic stimulation (TMS) is in use and is being evaluated in the NHS. There have been some promising results for deep brain stimulation and vagus nerve stimulation in the treatment of depression. Recently there have also been some very exciting studies which have shown that virtual reality has the potential to deliver rapid, lasting improvements in mental health.
This workshop is being run in collaboration with MindTech. It will take a biodesign approach and aims to bring together clinicians, companies, academics, charities and other stakeholders, to accelerate the development of new neurotechnologies to treat mood and psychotic disorders.
For any queries please contact:
Charlie Winkworth-Smith, Knowledge Transfer Manager Emerging Technologies
Poonam Phull, Events Manager
Follow the link below to find out more about this event and to register.